Review on Impact of COVID-19 on Cancer Care in India: Challenges, Disruptions, and Future Directions
DOI:
https://doi.org/10.52783/jns.v14.2876Keywords:
COVID 19, Cancer, Telemedicine, Vaccine efficacy, Health emergenciesAbstract
The COVID-19 pandemic has significantly disrupted global healthcare systems, with cancer care being notably affected. Millions of cancer patients worldwide have faced delayed diagnoses, treatment interruptions, and worsened outcomes due to the healthcare system's overburdening during the pandemic. The overlap between COVID-19 symptoms and cancer markers has created challenges in diagnosing and managing both conditions simultaneously. Cancer patients, particularly those undergoing active treatment, are at heightened risk for severe COVID-19 symptoms, further complicating their care. Additionally, the pandemic has exacerbated existing healthcare disparities, especially in rural and underserved areas, where access to cancer care is already limited. Financial burdens, psychological distress, and increased fear of recurrence further impact cancer patients' quality of life. The growing reliance on telemedicine has provided a temporary solution for continuity in care, though it presents challenges related to accessibility, patient satisfaction, and provider preferences. To prepare for future health emergencies, strengthening global collaboration, improving telemedicine infrastructure, and increasing cancer screening and prevention efforts are essential. This review highlights the profound impact of COVID-19 on cancer care and offers recommendations to mitigate these challenges in future crises.
Downloads
Metrics
References
Upadhyay A. Cancer: An unknown territory; rethinking before going ahead. Genes Dis. 2020 Sep 18;8(5):655-661. doi: 10.1016/j.gendis.2020.09.002.
Milibari AA. Current situation of coronavirus disease: (COVID-19) Review Article. Health Sci J 2020; 1-4.
Nagargoje B, Palod A, Dixi J, et al. Seroprevalence of COVID-19 in a city in India: A community-based cross-sectional study. J Res Med Dent Sci 2021; 9:48-53
Singh DK, Garg A, Bagri S, et al. COVID-19 presentation and effect of associated co-morbidities on severity of illness at a dedicated COVID hospital in North India. J Res Med Dent Sci 2021; 9:49-54.
Alisha Ishrath, Mohammed Mazher Ahmed, Namarata Pal, Siri Muppidi, Covid-19 (Pandemic): A Review Article, J Res Med Dent Sci, 2021, 9(10): 281-288.
Chavda VP, Ping FF, Chen ZS. An Impact of COVID-19 on Cancer Care: An Update. Vaccines (Basel). 2022 Dec 4;10(12):2072. doi: 10.3390/vaccines10122072.
Humaid O. Al‐Shamsi, Waleed Alhazzani, et al.., A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group, The Oncologist, Volume 25, Issue 6, June 2020, Pages e936–e945, https://doi.org/10.1634/theoncologist.2020-0213
Wu J.T.-Y., Kwon D.H., Glover M.J., Henry S., Wood D., Rubin D.L., Koshkin V.S., Schapira L., Shah S.A. Changes in Cancer Management Due to COVID-19 Illness in Patients with Cancer in Northern California. Jco Oncol. Pr. 2021;17:e377–e385. doi: 10.1200/OP.20.00790.
Chavda V.P., Vihol D., Mehta B., Shah D., Patel M., Vora L.K., Pereira-Silva M., Paiva-Santos A.C. Phytochemical-Loaded Liposomes for Anticancer Therapy: An Updated Review. Nanomedicine. 2022;17:547–568. doi: 10.2217/nnm-2021-0463.
Lee K.A., Ma W., Sikavi D.R., Drew D.A., Nguyen L.H., Bowyer R.C.E., Cardoso M.J., Fall T., Freidin M.B., Gomez M., et al. Cancer and Risk of COVID-19 Through a General Community Survey. Oncologist. 2021;26:e182–e185. doi: 10.1634/theoncologist.2020-0572.
.Barrière J., Chamorey E., Adjtoutah Z., Castelnau O., Mahamat A., Marco S., Petit E., Leysalle A., Raimondi V., Carles M. Impaired Immunogenicity of BNT162b2 Anti-SARS-CoV-2 Vaccine in Patients Treated for Solid Tumors. Ann. Oncol. 2021;32:1053–1055. doi: 10.1016/j.annonc.2021.04.019.
Gruell H., Vanshylla K., Tober-Lau P., Hillus D., Schommers P., Lehmann C., Kurth F., Sander L.E., Klein F. MRNA Booster Immunization Elicits Potent Neutralizing Serum Activity against the SARS-CoV-2 Omicron Variant. Nat. Med. 2022;28:477–480. doi: 10.1038/s41591-021-01676-0.
Chavda V.P., Prajapati R., Lathigara D., Nagar B., Kukadiya J., Redwan E.M., Uversky V.N., Kher M.N., Patel R. Therapeutic Monoclonal Antibodies for COVID-19 Management: An Update. Expert Opin. Biol. Ther. 2022;22:763–780. doi: 10.1080/14712598.2022.2078160.
Barrière J., Zalcman G., Fignon L., Peiffer-Smadja N., Audigier-Valette C., Carles M. Omicron Variant: A Clear and Present Danger for Patients with Cancer. Eur. J. Cancer. 2022;165:25–26. doi: 10.1016/j.ejca.2022.01.010.
Bagheri G., Thiede B., Hejazi B., Schlenczek O., Bodenschatz E. An Upper Bound on One-to-One Exposure to Infectious Human Respiratory Particles. Proc. Natl. Acad. Sci. USA. 2021;118:e2110117118. doi: 10.1073/pnas.2110117118.
Monin L., Laing A.G., Muñoz-Ruiz M., McKenzie D.R., del Molino del Barrio I., Alaguthurai T., Domingo-Vila C., Hayday T.S., Graham C., Seow J., et al. Safety and Immunogenicity of One versus Two Doses of the COVID-19 Vaccine BNT162b2 for Patients with Cancer: Interim Analysis of a Prospective Observational Study. Lancet Oncol. 2021;22:765–778. doi: 10.1016/S1470-2045(21)00213-8.
Lee M., Quinn R., Pradhan K., Fedorov K., Levitz D., Fromowitz A., Thakkar A., Shapiro L.C., Kabarriti R., Ruiz R.E., et al. Impact of COVID-19 on Case Fatality Rate of Patients with Cancer during the Omicron Wave. Cancer Cell. 2022;40:343–345. doi: 10.1016/j.ccell.2022.02.012.
wang J.K., Zhang T., Wang A.Z., Li Z. COVID-19 Vaccines for Patients with Cancer: Benefits Likely Outweigh Risks. J. Hematol. Oncol. 2021;14:38. doi: 10.1186/s13045-021-01046-w.
Chavda VP, Ping FF, Chen ZS. An Impact of COVID-19 on Cancer Care: An Update. Vaccines (Basel). 2022 Dec 4;10(12):2072. doi: 10.3390/vaccines10122072.
Shankar A, Saini D, Richa, Goyal N, Roy S, Angural H, Kaushal V, Bharati SJ, Upadhyaya R, Durga T. Cancer Care Delivery Challenges in India during the COVID-19 Era: Are We Prepared for the Postpandemic Shock? Asia Pac J Oncol Nurs. 2020 Nov 21;8(1):1-4. doi: 10.4103/apjon.apjon_57_20.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492.
Shankar A, Saini D, Bhandari R, Bharati SJ, Kumar S, Yadav G, et al. Lung cancer management challenges amidst COVID-19 pandemic: Hope lives here. Lung Cancer Manag. 2020;9:LMT33. doi: 10.2217/lmt-2020-0012.
Möller TR, Brorsson B, Ceberg J, Frödin JE, Lindholm C, Nylén U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol (Stockholm, Sweden) 2003;42:387–410. doi: 10.1080/02841860310011131.
National Institute of Health and Care Excellence. COVID-19 Rapid Guideline: Delivery of Systemic Anticancer Treatments. 2020. [Last accessed on 2020 Jul 26]. Available from: https://wwwniceorguk/guidance/NG161 . [PubMed]
Merz V, Ferro A, Piras EM, Zanutto A, Caffo O, Messina C. Electronic medical record-assisted telephone follow-up of breast cancer survivors during the COVID-19 pandemic: a single institution experience. JCO Oncol Pract. 2021;17(1):e44–e52. doi: 10.1200/OP.20.00643.
Yang G, Xiao C, Li S, Yang N. The effect and mechanism of adverse childhood experience on suicide ideation in young cancer patients during coronavirus disease 2019 (COVID-19) pandemic. Risk Manag Healthc Policy. 2020;13:1293–1300. doi: 10.2147/RMHP.S266269.
Seth T, Shankar A, Roy S, Saini D. Hemato-oncology care in COVID-19 pandemic: Crisis within a crisis. Asian Pac J Cancer Prev. 2020;21:1173–5. doi: 10.31557/APJCP.2020.21.5.1173.
Schandl A, Mälberg K, Johar A, Lagergren P. Social distancing during the COVID-19 pandemic and health-related quality of life among esophageal cancer survivors. Acta Oncol. 2021;60(8):1011–1018. doi: 10.1080/0284186X.2021.1921260.
Zhao F, Henderson TO, Cipriano TM, et al. The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort. Cancer. 2021;127(21):4072–4080. doi: 10.1002/cncr.33798.
van De Poll-Franse LV, De Rooij BH, Horevoorts NJ, et al. Perceived care and well-being of patients with cancer and matched norm participants in the COVID-19 crisis: results of a survey of participants in the Dutch PROFILES Registry. JAMA Oncol. 2021;7(2):279–284. doi: 10.1001/jamaoncol.2020.6093.
Bartels MM, Gal R, van der Velden JM, Verhoeff JJ, Verlaan JJ, Verkooijen HM. Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study. Clin Exp Metastasis. 2021;38(2):209–217. doi: 10.1007/s10585-021-10079-x.
Ciążyńska M, Pabianek M, Szczepaniak K, et al. Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic. Psycho-oncology. 2020;29(9):1377–1379. doi: 10.1002/pon.5434.
Ellehuus C, Jeppesen SS, Eckhoff L, et al. Health-related quality of life of patients with haematologic cancer during COVID-19 and their opinions on telehealth consultations–a Danish single site cross-sectional survey. Acta Oncol. 2021;60(7):872–880. doi: 10.1080/0284186X.2021.1902565.
Rodriguez GM, Ferguson JM, Kurian A, Bondy M, Patel MI. The Impact of COVID-19 on Patients with Cancer: A National Study of Patient Experiences. Am J Clin Oncol. 2021;44(11):580–587. doi: 10.1097/COC.0000000000000865.
Muls A, Georgopoulou S, Hainsworth E, Hartley B, O'Gara G, Stapleton S, Cruickshank S. The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic review. Semin Oncol. 2022 Oct;49(5):371-382. doi: 10.1053/j.seminoncol.2022.08.001. Epub 2022 Aug 22.
Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92:577–83. doi: 10.1002/jmv.25757.
Barlesi F, Foulon S, Bayle A, Gachot B, Pommeret F, Willekens C, et al. Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments. AACR Annual Meeting 2020 Online. 2020;April 28 abstr.CT403.
Vuagnat P, Frelaut M, Ramtohul T, Basse C, Diakite S, Noret A, et al. COVID-19 in breast cancer patients: a cohort at the institute curie hospitals in the Paris area. Breast Cancer Res. 2020;22:55. doi: 10.1186/s13058-020-01293-8.
Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Clinical characteristics and outcomes of cancer patients With COVID-19. J Med Virol. 2020 doi: 10.1002/jmv.25972. DOI : 10.1002/jmv.25972.
Liang B, Yang N, He G, Huang P, Yang Y. Identification of the Facial Features of Patients With Cancer: A Deep Learning-Based Pilot Study. J Med Internet Res. 2020 Apr 29;22(4):e17234. doi: 10.2196/17234. https://www.jmir.org/2020/4/e17234/
The rise of the data-driven physician. Stanford University. 2020. [2020-10-16]. https://med.stanford.edu/content/dam/sm/school/documents/Health-Trends-Report/Stanford%20Medicine%20Health%20Trends%20Report%202020.pdf.
Lee A, Moy L, Kruck SE, Rabang J. The doctor is in, but is academia? Re-tooling IT education for a new era in healthcare. Journal of Information Systems Education. 2014;25(4):275–282. https://aisel.aisnet.org/jise/vol25/iss4/1/
Carroll N, Richardson I, Moloney M, O’Reilly P. Bridging healthcare education and technology solution development through experiential innovation. Health Technol. 2017 Nov 7;8(4):255–261. doi: 10.1007/s12553-017-0209-z.
Abuelgasim E, Saw LJ, Shirke M, Zeinah M, Harky A. COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities. Curr Probl Cardiol. 2020;August 2020:100621. doi: 10.1016/j.cpcardiol.2020.100621.
C. Kitamura HBSc,* L. Zurawel–Balaura HBSc,* and R.K.S. Wong MSc* MBChB How effective is video consultation in clinical oncology. A systematic review. doi: 10.3747/co.v17i3.513.
Tashkandi E, Zeeneldin A, AlAbdulwahab A, Elemam O, Elsamany S, Jastaniah W, et al. Virtual Management of Cancer Patients in the Era of COVID-19 Pandemic. J Med Internet Res [Internet] 2020 doi: 10.2196/19691. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32501807 .
Triantafillou V, Rajasekaran K. A Commentary on the Challenges of Telemedicine for Head and Neck Oncologic Patients during COVID-19. Otolaryngol neck Surg Off J Am Acad Otolaryngol Neck Surg. 2020:194599820923622. doi: 10.1177/0194599820923622.
Gray J, Brain K, Iredale R, Alderman J, France E, Hughes H. A pilot study of telegenetics. J Telemed Telecare. 2000;6:245–7. doi: 10.1258/1357633001935329
Hong YR, Lawrence J, Williams D Jr, Mainous III A. Population-Level Interest and Telehealth Capacity of US Hospitals in Response to COVID-19: Cross-Sectional Analysis of Google Search and National Hospital Survey Data. JMIR Public Health Surveill. 2020;6(2):e18961. doi: 10.2196/18961.
30.Raffenaud Amanda, et al. ‘Utilizing Telemedicine in Oncology Settings: Patient Favourability Rates and Perceptions of Use Analysis Using Chi-Square and Neural Networks’. 2019;115:127. doi: 10.3233/THC-181293.
Noar SM, Harrington NG, Aldrich RS. The Role of Message Tailoring in the Development of Persuasive Health Communication Messages. Annals of the International Communication Association. 2016 May 18;33(1):73–133. doi: 10.1080/23808985.2009.11679085.
Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. The Lancet. 2010 Oct;376(9748):1261–1271. doi: 10.1016/s0140-6736(10)60809-4.
Key TM, Czaplewski AJ. Upstream social marketing strategy: An integrated marketing communications approach. Business Horizons. 2017 May;60(3):325–333. doi: 10.1016/j.bushor.2017.01.006.
Patti C, Hartley S, van Dessel M, Baack D. Improving integrated marketing communications practices: A comparison of objectives and results. Journal of Marketing Communications. 2015 Apr 23;23(4):351–370. doi: 10.1080/13527266.2015.1027251.
Cancino RS, Su Z, Mesa R, Tomlinson GE, Wang J. The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities. JMIR Cancer. 2020 Oct 29;6(2):e21697. doi: 10.2196/21697.
Pennell NA, Dillmon M, Levit LA, et al (2021). American Society of Clinical oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. J Clin Oncol, 39, 155-69.
Di Lorenzo G, Di Trolio R, Kozlakidis Z, et al (2020). COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature. Crit Rev Oncol Hematol, 152, 102991.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
